Similarly, using a TGFβ signaling-deficient model of colon cancer, it was shown that increased numbers of iMCs are recruited from the bone marrow to the invasive front of liver metastases, in response to a gradient of CCL9 [74]. This evidence concerns the gene TGFB1 and malignant colon neoplasm.